The first clinical site is now active for a global Phase 3 study that will evaluate Gossamer Bio’s therapy candidate seralutinib in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Dubbed SERANATA, the study aims to enroll about 480 people with PH-ILD, ages 18 to 80. No…
Read more
Before I was diagnosed with pulmonary hypertension (PH), my life moved at full speed. I worked full time as a hospice care nurse, a job that was both emotionally demanding and deeply fulfilling. I was an active wife and mom, constantly on the go. Many of my mornings started…
Treprostinil may help manage pulmonary hypertension (PH) in children who’ve undergone Fontan surgery for congenital heart defects, according to a study in China. The treatment was associated with lower mean pulmonary arterial pressure (PAP) and improved oxygenation — oxygen delivery to tissues. The therapy was well tolerated, with no…
Get regular updates to your inbox.
